These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Coulson BS, Tursi JM, McAdam WJ, Bishop RF. Virology; 1986 Oct 30; 154(2):302-12. PubMed ID: 2429439 [Abstract] [Full Text] [Related]
31. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ. J Virol; 1988 Mar 30; 62(3):744-8. PubMed ID: 2828669 [Abstract] [Full Text] [Related]
32. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. Offit PA, Clark HF, Blavat G, Greenberg HB. J Virol; 1986 Nov 30; 60(2):491-6. PubMed ID: 3021983 [Abstract] [Full Text] [Related]
33. Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates. Palombo EA, Bishop RF, Cotton RG. Arch Virol; 1993 Nov 30; 133(3-4):323-34. PubMed ID: 7504915 [Abstract] [Full Text] [Related]
35. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. Coulson BS, Kirkwood C. J Virol; 1991 Nov 30; 65(11):5968-74. PubMed ID: 1656083 [Abstract] [Full Text] [Related]
36. Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. Kobayashi N, Taniguchi K, Urasawa S. J Gen Virol; 1990 Nov 30; 71 ( Pt 11)():2615-23. PubMed ID: 1701477 [Abstract] [Full Text] [Related]